• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄对大鼠吡罗昔康药代动力学的影响。

Effects of age on the pharmacokinetics of piroxicam in rats.

作者信息

Boudinot S G, Funderburg E D, Boudinot F D

机构信息

Department of Pharmaceutics, College of Pharmacy, University of Georgia, Athens 30602.

出版信息

J Pharm Sci. 1993 Mar;82(3):254-7. doi: 10.1002/jps.2600820307.

DOI:10.1002/jps.2600820307
PMID:8450417
Abstract

This study examined the effects of age on the pharmacokinetics of piroxicam in rats. Two groups of rats, aged 5 and 24 months, were administered 1 mg of piroxicam per kg intravenously, and blood samples were withdrawn for up to 120 h. Protein binding studies, with pooled serum from each age group were also performed. Piroxicam concentrations were determined by HPLC analysis, and pharmacokinetic parameters were characterized by area-moment analysis. Plasma piroxicam concentrations declined in both age groups in a biexponential fashion, with half-lives of 5.9 +/- 0.7 h (mean +/- SD) in the young rats and 30.6 +/- 9.9 h in the old rats. Total clearance in the young rats was 0.048 +/- 0.012 L/h/kg, whereas that in the old rats was 0.021 +/- 0.003 L/h/kg. The steady-state volume of distribution in the young rats was 0.42 +/- 0.05 L/kg, and that in the old rats was 0.56 +/- 0.10 L/kg. There was a statistically significant difference between these parameters calculated for each age group. Piroxicam is a highly plasma protein-bound drug; the fraction unbound in the young rats was determined to be 0.067 +/- 0.022, and that in the old rats was determined to be 0.134 +/- 0.065, or twice that in the young rats. Differences in protein binding were due, in part, to a 20% decreased albumin concentration in the old rats; however, there was also a decrease in the number of binding sites and/or the binding affinity with aging.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

本研究考察了年龄对吡罗昔康在大鼠体内药代动力学的影响。将两组分别为5月龄和24月龄的大鼠静脉注射1 mg/kg的吡罗昔康,并在长达120小时内采集血样。还采用各年龄组的混合血清进行了蛋白结合研究。通过高效液相色谱分析测定吡罗昔康浓度,并采用面积矩分析法表征药代动力学参数。两个年龄组的血浆吡罗昔康浓度均呈双指数下降,幼鼠的半衰期为5.9±0.7小时(均值±标准差),老龄鼠为30.6±9.9小时。幼鼠的总清除率为0.048±0.012 L/h/kg,而老龄鼠为0.021±0.003 L/h/kg。幼鼠的稳态分布容积为0.42±0.05 L/kg,老龄鼠为0.56±0.10 L/kg。各年龄组计算得到的这些参数之间存在统计学显著差异。吡罗昔康是一种血浆蛋白高度结合的药物;幼鼠中未结合部分测定为0.067±0.022,老龄鼠中为0.134±0.065,是幼鼠的两倍。蛋白结合的差异部分归因于老龄鼠白蛋白浓度降低20%;然而,随着年龄增长,结合位点数量和/或结合亲和力也有所下降。(摘要截断于250字)

相似文献

1
Effects of age on the pharmacokinetics of piroxicam in rats.年龄对大鼠吡罗昔康药代动力学的影响。
J Pharm Sci. 1993 Mar;82(3):254-7. doi: 10.1002/jps.2600820307.
2
Effects of dose and sex on the pharmacokinetics of piroxicam in the rat.
Biopharm Drug Dispos. 1990 Apr;11(3):215-25. doi: 10.1002/bdd.2510110306.
3
The pharmacokinetics of piroxicam in elderly persons with and without renal impairment.吡罗昔康在有和没有肾功能损害的老年人中的药代动力学。
Br J Clin Pharmacol. 1994 Jan;37(1):1-5. doi: 10.1111/j.1365-2125.1994.tb04230.x.
4
Effect of induced hypoalbuminemia on distribution, total clearance and unbound clearance of piroxicam in vivo in the rat.诱导性低白蛋白血症对大鼠体内吡罗昔康分布、总清除率及非结合清除率的影响。
Eur J Drug Metab Pharmacokinet. 1993 Apr-Jun;18(2):165-71. doi: 10.1007/BF03188792.
5
Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.昔康类非甾体抗炎药的药代动力学
Clin Pharmacokinet. 1994 Feb;26(2):107-20. doi: 10.2165/00003088-199426020-00004.
6
Oxaprozin and piroxicam, nonsteroidal antiinflammatory drugs with long half-lives: effect of protein-binding differences on steady-state pharmacokinetics.奥沙普秦和吡罗昔康,两种半衰期较长的非甾体抗炎药:蛋白结合差异对稳态药代动力学的影响。
J Clin Pharmacol. 1997 Apr;37(4):267-78. doi: 10.1002/j.1552-4604.1997.tb04302.x.
7
Pharmacokinetics of ketoprofen in rats: effect of age and dose.酮洛芬在大鼠体内的药代动力学:年龄和剂量的影响。
Biopharm Drug Dispos. 1992 Apr;13(3):197-212. doi: 10.1002/bdd.2510130306.
8
Pharmacokinetics of piroxicam in rats.吡罗昔康在大鼠体内的药代动力学。
Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:80-4.
9
The effect of age on piroxicam disposition in rheumatoid arthritis.年龄对类风湿关节炎患者吡罗昔康处置的影响。
J Rheumatol. 1988;15(5):757-63.
10
Piroxicam-natural polymers interactions.吡罗昔康与天然聚合物的相互作用。
Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:397-405.

引用本文的文献

1
The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis.衰老的肝脏。药物清除与氧扩散屏障假说。
Clin Pharmacokinet. 1998 May;34(5):359-73. doi: 10.2165/00003088-199834050-00003.
2
Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance.美洛昔康(一种具有良好胃肠道耐受性的新型非甾体抗炎药)的抗炎、镇痛、解热及相关特性。
Inflamm Res. 1995 Oct;44(10):423-33. doi: 10.1007/BF01757699.